We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
176
Ultragenyx Pharmaceutical
RARE
$2.82B
$23M 0.12%
1,096,182
+296,798
+37% +$6.68M
CBRE icon
177
CBRE Group
CBRE
$40.5B
$22.7M 0.12%
167,770
+2,577
+2% +$392K
AIG icon
178
American International
AIG
$42.5B
$22.6M 0.12%
300,112
+209,030
+229% +$16M
CYTK icon
179
Cytokinetics
CYTK
$11B
$22.1M 0.11%
335,208
+188,577
+129% +$12M
BCRX icon
180
BioCryst Pharmaceuticals
BCRX
$2.39B
$21.8M 0.11%
+2,286,841
New +$17.8M
MLYS icon
181
Mineralys Therapeutics
MLYS
$2.43B
$21.7M 0.11%
801,904
+123,517
+18% +$3.62M
SNDX icon
182
Syndax Pharmaceuticals
SNDX
$2.01B
$21.6M 0.11%
925,332
– –
EL icon
183
Estee Lauder
EL
$29.8B
$21.6M 0.11%
301,032
+208,628
+226% +$21.3M
COHR icon
184
Coherent
COHR
$62.1B
$21.2M 0.11%
89,135
+14,007
+19% +$3.21M
ORCL icon
185
Oracle
ORCL
$366B
$21.2M 0.11%
144,283
-1,943
-1% -$316K
DNLI icon
186
Denali Therapeutics
DNLI
$3.78B
$21.1M 0.11%
1,099,845
-66,534
-6% -$1.32M
EW icon
187
Edwards Lifesciences
EW
$48.7B
$20.8M 0.11%
260,327
+25,359
+11% +$2.09M
FUTU icon
188
Futu Holdings
FUTU
$14.5B
$20.8M 0.11%
152,249
-31,797
-17% -$4.94M
VIST icon
189
Vista Energy
VIST
$7.25B
$20.8M 0.11%
+275,600
New +$16.1M
BBIO icon
190
BridgeBio Pharma
BBIO
$16.1B
$20.7M 0.11%
278,888
– –
YPF icon
191
YPF
YPF
$20.1B
$20.5M 0.11%
444,000
+297,000
+202% +$11.2M
PRAX icon
192
Praxis Precision Medicines
PRAX
$8.86B
$20.5M 0.11%
63,628
-46,962
-42% -$14.5M
LULU icon
193
lululemon athletica
LULU
$13.2B
$20.5M 0.11%
133,856
+76,777
+135% +$13.8M
DGX icon
194
Quest Diagnostics
DGX
$22.9B
$20.4M 0.11%
104,136
+2,409
+2% +$468K
FSLR icon
195
First Solar
FSLR
$22.1B
$20.3M 0.11%
102,792
-10,052
-9% -$2.22M
ORKA
196
Oruka Therapeutics
ORKA
$5.69B
$20.2M 0.1%
411,006
+10,497
+3% +$365K
VLTO icon
197
Veralto
VLTO
$22.1B
$20.1M 0.1%
226,804
+15,839
+8% +$1.51M
EQIX icon
198
Equinix
EQIX
$101B
$19.8M 0.1%
20,218
+317
+2% +$282K
MFC icon
199
Manulife Financial
MFC
$71.2B
$19.6M 0.1%
570,607
-145,439
-20% -$5.23M
IAG icon
200
IAMGOLD
IAG
$8.65B
$19.2M 0.1%
1,020,000
-520,000
-34% -$10.3M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.